Zydus Life Science P/B Ratio
Zydus Life Science P/B ratio. Zydus Life Science (ZYDUSLIFE) P/B ratio is 4.14 (High), book value per share ₹2928.91 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Analyse Zydus Life Science shareholding analysis to track promoter, FII and institutional holdings.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
ZYDUSLIFE P/B Ratio — Valuation Insights & Book Value Analysis
Zydus Life Science price-to-book ratio interpretation, valuation status and historical context — current P/B 4.14 (High). View ZYDUSLIFE 52-week chart for the annual high/low range and current price position.
- Stock appears overvalued with PB of 4.14, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 1082.9% above historical average
- Trading at premium to sector average PB of -0.01
Zydus Life Science P/B Ratio Historical Trend
ZYDUSLIFE annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Zydus Life Science stock price NSE.
ZYDUSLIFE Historical P/B Ratio — Book Value Per Share & Year-End Price
Zydus Life Science annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.39 | ₹2928.91 | ₹1135.00 | ₹29,582 | Low |
| 2025 | 0.35 | ₹2609.7 | ₹914.35 | ₹26,358 | Low |
| 2024 | 0.44 | ₹2188.32 | ₹971.70 | ₹22,102 | Low |
| 2023 | 0.35 | ₹1949.31 | ₹689.20 | ₹19,688 | Low |
| 2022 | 0.22 | ₹1868.04 | ₹419.95 | ₹19,054 | Low |
ZYDUSLIFE vs Healthcare Peers — P/B Ratio Comparison
Zydus Life Science P/B 4.14 vs Healthcare average -0.01, median 0.6 — range -6.55–1.06.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.32 | ₹43 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.79 | ₹130 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.22 | ₹53 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |